By Weiyang Li, Chris Masick, and Humberto Vega-Mercado, Bristol Myers Squibb
Cryo-shippers are essential for shipping advanced therapeutics, but how do you choose and validate the right one? This article from BMS experts offers insights.
By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.
Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.
This webinar discusses the types of master protocols and how configurable, modern RTSM systems enable fast and seamless mid-study changes to help you efficiently run your master protocol study.
Combined with the inherent difficulty of the chemistry behind gene therapy development, its pace, structure, and funding dynamics are unique among treatment modalities.
Explore the challenges when moving a bioconjugate candidate from early development to clinic, along with integrated solutions for navigating this growing area of the biopharmaceutical industry.
Explore the impact of the pandemic on trial operations and what the future of RTSM technology looks like with Medrio’s internal RTSM expert, Ian Davison.
e-book | By Kristen DeVito and Jan Ehrich, Catalent
Drive excellence in clinical trials by utilizing forecasting to better plan clinical supply budgets, project timelines, and identify potential supply-related issues before they negatively impact a study.